Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems

scientific article published in October 2007

Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1166/JNN.2007.809
P698PubMed publication ID18330178

P50authorAlessandro MauroQ41333345
P2093author name stringMaria Rosa Gasco
Franco Fraschini
Lorenzo Priano
Roberto Esposti
Clotilde De Medici
Giovanna Castagna
Daniele Esposti
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
melatoninQ180912
P304page(s)3596-3601
P577publication date2007-10-01
P1433published inJournal of Nanoscience and NanotechnologyQ2364336
P1476titleSolid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems
P478volume7

Reverse relations

cites work (P2860)
Q28260432A look at emerging delivery systems for topical drug products
Q59018410An Investigation of Optimum NLC-Sunscreen Formulation Using Taguchi Analysis
Q33914484Biphasic flux profiles of melatonin: the Yin-Yang of transdermal permeation enhancement mediated by fatty alcohol enhancers
Q37715006Chapter 10 - Solid lipid nanoparticles and microemulsions for drug delivery The CNS.
Q43869233Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery
Q37096490Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.
Q48419057Different particulate systems--bypass the biological barriers?
Q42944298Evaluation of biocompatible stabilised gelled soya bean oil nanoparticles as new hydrophobic reservoirs
Q39096524In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate.
Q39437287Lecithin/chitosan nanoparticles for transdermal delivery of melatonin
Q26859021Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives
Q38324016Lipid nanoparticles for the topical delivery of retinoids and derivatives
Q37038862Nanovector
Q46183692Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension
Q37235719New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists
Q42011994Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats
Q37735764Phospholipids and lipid-based formulations in oral drug delivery
Q92503984Protective effects of melatonin solid lipid nanoparticles on testis histology after testicular trauma in rats
Q34733880Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery
Q47107006Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies.
Q42843043Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies
Q49719878Systemic and transdermal melatonin administration prevents neuropathology in response to perinatal asphyxia in newborn lambs.
Q34016650Use of transdermal melatonin delivery to improve sleep maintenance during daytime

Search more.